Advertisement
cancer talk
  • Clinical Trials: An African American Survivor’s Experience

    Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

    by Melvin Mann

  • Food Insecurity and Cancer

    After discovering that some patients weren't able to access the food they needed, a community oncology practice partnered with a local food bank.

    by Jen Tota McGivney

  • “Congrats! You Have the ‘Good’ Cancer”

    Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

    by Carly Flumer

  • 2019: This Year in Cancer News

    The Cancer Today editorial staff selects some of the most impactful and informative reporting and essays of 2019.

    by Cancer Today Staff

  • Progress, But Still Room for Improvement

    The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.

    by Kevin McLaughlin

  • Telling Your Children About Inheritable Cancer Risk

    Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

    by Marci A. Landsmann

  • Noble Art

    Art therapist and licensed clinical professional counselor Jacqueline Carmody describes how a unique art therapy program helps people affected by cancer.

    by Bradley Jones

  • How Disability Insurers Monitor Patients Online

    Companies that offer disability insurance may monitor patients' social media accounts to determine if they qualify for the benefits being received.

    by Kate Yandell

  • Cancer Patient Advocates Find Strength in Numbers

    Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

    by Marci A. Landsmann

  • Exploring Immunotherapy for Triple Negative Breast Cancer

    Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

    by Marci A. Landsmann